These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33187966)

  • 1. Conditional Relative Survival and Competing Mortality of Patients with Prostate Cancer in Korea: A Nationwide Cohort Study.
    Park J; Han K; Shin DW; Park SH; Shin HB
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):326-334. PubMed ID: 33187966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: A nationwide cohort study.
    Yoo JE; Han K; Shin DW; Park SH; Cho IY; Yoon DW; Cho J; Jung KW
    Int J Cancer; 2021 Feb; 148(3):626-636. PubMed ID: 32738818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of death among cancer patients in the era of cancer survivorship in Korea: Attention to the suicide and cardiovascular mortality.
    Oh CM; Lee D; Kong HJ; Lee S; Won YJ; Jung KW; Cho H
    Cancer Med; 2020 Mar; 9(5):1741-1752. PubMed ID: 31960609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
    Narita S; Nomura K; Hatakeyama S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Ohyama C; Arai Y; Nagashima K; Habuchi T
    Cancer Med; 2019 Nov; 8(15):6566-6577. PubMed ID: 31508900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016.
    Elmehrath AO; Afifi AM; Al-Husseini MJ; Saad AM; Wilson N; Shohdy KS; Pilie P; Sonbol MB; Alhalabi O
    JAMA Netw Open; 2021 Aug; 4(8):e2119568. PubMed ID: 34351403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncancer deaths in white adult cancer patients.
    Brown BW; Brauner C; Minnotte MC
    J Natl Cancer Inst; 1993 Jun; 85(12):979-87. PubMed ID: 8496983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause of death during prostate cancer survivorship: A contemporary, US population-based analysis.
    Weiner AB; Li EV; Desai AS; Press DJ; Schaeffer EM
    Cancer; 2021 Aug; 127(16):2895-2904. PubMed ID: 33882145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea.
    Kang J; Shin DW; Han K; Park SH; Lee WG; Yoo JE; Woo SH; Park J
    Curr Probl Cancer; 2020 Dec; 44(6):100578. PubMed ID: 32360240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cause of Death in Korean Men with Prostate Cancer: an Analysis of Time Trends in a Nationwide Cohort.
    Park J; Suh B; Shin DW; Hong JH; Ahn H
    J Korean Med Sci; 2016 Nov; 31(11):1802-1807. PubMed ID: 27709860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Patterns of Excess Mortality among Endometrial Cancer Survivors.
    Anderson C; Bae-Jump VL; Broaddus RR; Olshan AF; Nichols HB
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1079-1088. PubMed ID: 33737298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based study.
    Ye Y; Otahal P; Marwick TH; Wills KE; Neil AL; Venn AJ
    Cancer; 2019 Feb; 125(3):442-452. PubMed ID: 30311655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea.
    Jung YS; Lee D; Jung KW; Cho H
    Cancer Res Treat; 2023 Jan; 55(1):50-60. PubMed ID: 35698446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause-specific mortality in survivors of adolescent and young adult cancer.
    Armenian SH; Xu L; Cannavale KL; Wong FL; Bhatia S; Chao C
    Cancer; 2020 May; 126(10):2305-2316. PubMed ID: 32129881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
    Tendulkar RD; Hunter GK; Reddy CA; Stephans KL; Ciezki JP; Abdel-Wahab M; Stephenson AJ; Klein EA; Mahadevan A; Kupelian PA
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):94-9. PubMed ID: 23920389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study.
    Shin DW; Bae J; Ha J; Jung KW
    J Gynecol Oncol; 2021 Jan; 32(1):e5. PubMed ID: 33185046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
    Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ
    Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
    Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
    Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
    [No Abstract]   [Full Text] [Related]  

  • 18. Late mortality from other diseases following childhood cancer in Australia and the impact of intensity of treatment.
    Youlden DR; Walwyn TS; Cohn RJ; Harden HE; Pole JD; Aitken JF
    Pediatr Blood Cancer; 2021 May; 68(5):e28835. PubMed ID: 33314726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Korea.
    Shin DW; Han K; Park HS; Lee SP; Park SH; Park J
    Sci Rep; 2020 Jun; 10(1):10313. PubMed ID: 32587285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.